4//SEC Filing
LEE KENNETH B JR 4
Accession 0001127602-21-025331
CIK 0000882796other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:26 PM ET
Size
8.2 KB
Accession
0001127602-21-025331
Insider Transaction Report
Form 4
LEE KENNETH B JR
Director
Transactions
- Sale
Common Stock
2021-09-13$15.35/sh−6,000$92,100→ 24,252 total - Exercise/Conversion
Common Stock
2021-09-13$3.22/sh+15,000$48,300→ 30,252 total - Exercise/Conversion
Automatic Stock Option Grant
2021-09-13−15,000→ 0 totalExercise: $3.32From: 2012-06-23Exp: 2022-05-23→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.24 to $15.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001208570
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:26 PM ET
- Size
- 8.2 KB